相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells
Mamoru Tanaka et al.
BMC CANCER (2013)
Combination of Albendazole and 2-Methoxyestradiol significantly improves the survival of HCT-116 tumor-bearing nude mice
Anahid Ehteda et al.
BMC CANCER (2013)
Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway
Howard A. Burris
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Angiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activation
Tao Li et al.
CANCER LETTERS (2013)
Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma
Peng Xiu et al.
CANCER SCIENCE (2013)
STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells
Zheng Wei et al.
CELLULAR SIGNALLING (2013)
AKT as locus of cancer multidrug resistance and fragility
Ziv Radisavljevic
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Hypoxia inducible factor-1a-mediated activation of survivin in cervical cancer cells
Haitao Bai et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2013)
Suppression of Survivin Induced by a BCR-ABL/JAK2/STAT3 Pathway Sensitizes Imatinib-Resistant CML Cells to Different Cytotoxic Drugs
Stefania Stella et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo
Zheng Wei et al.
TUMOR BIOLOGY (2013)
Concomitant Targeting of Tumor Cells and Induction of T-cell Response Synergizes to Effectively Inhibit Trastuzumab-Resistant Breast Cancer
Qingfei Wang et al.
CANCER RESEARCH (2012)
Downregulating hypoxia-inducible factor-2a improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma
Changjun He et al.
CANCER SCIENCE (2012)
HIF1α regulated expression of XPA contributes to cisplatin resistance in lung cancer
Yanbin Liu et al.
CARCINOGENESIS (2012)
ABT-737 Synergizes with Arsenic Trioxide to Induce Apoptosis of Gastric Carcinoma Cells In Vitro and In Vivo
X. P. Sun et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
YM155 Reverses Cisplatin Resistance in Head and Neck Cancer by Decreasing Cytoplasmic Survivin Levels
Bhavna Kumar et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Thimerosal-Induced Apoptosis in Mouse C2C12 Myoblast Cells Occurs through Suppression of the PI3K/Akt/Survivin Pathway
Wen-Xue Li et al.
PLOS ONE (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells
Christoph Wohlkoenig et al.
CANCER LETTERS (2011)
Combination of Farnesyltransferase and Akt Inhibitors Is Synergistic in Breast Cancer Cells and Causes Significant Breast Tumor Regression in ErbB2 Transgenic Mice
Maria E. Balasis et al.
CLINICAL CANCER RESEARCH (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
Regulation of survivin by PI3K/Akt/p70S6K1 pathway
Peng Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy
Chun Hei Antonio Cheung et al.
CANCER CELL INTERNATIONAL (2010)
Antisense HIF-1α prevents acquired tumor resistance to angiostatin gene therapy
X. Sun et al.
CANCER GENE THERAPY (2010)
Distinct Biological Roles for the Akt Family in Mammary Tumor Progression
Rachelle L. Dillon et al.
CANCER RESEARCH (2010)
HIF-1 and HIF-2 transcription factors - Similar but not identical
Agnieszka Loboda et al.
MOLECULES AND CELLS (2010)
Hypoxia-Inducible Factor 1α Determines Gastric Cancer Chemosensitivity via Modulation of p53 and NF-κB
Nadine Rohwer et al.
PLOS ONE (2010)
The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy
Matthew D. Hall et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
The role of hypoxia-inducible factors in tumorigenesis
E. B. Rankin et al.
CELL DEATH AND DIFFERENTIATION (2008)
Hypoxia-inducible transcription factor-2α in endothelial cells regulates tumor neovascularization through activation of ephrin A1
Toshiharu Yamashita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
CCL2 Protects Prostate Cancer PC3 Cells from Autophagic Death via Phosphatidylinositol 3-Kinase/AKT-dependent Survivin Up-regulation
Hernan Roca et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
Wasaburo Koizumi et al.
LANCET ONCOLOGY (2008)
YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts
Takahito Nakahara et al.
CANCER RESEARCH (2007)
Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation
LL Belyanskaya et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt
L Yang et al.
CANCER RESEARCH (2004)
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
NJ Mabjeesh et al.
CANCER CELL (2003)
Validating survivin as a cancer therapeutic target
DC Altieri
NATURE REVIEWS CANCER (2003)
Mechanisms of resistance to cisplatin
M Kartalou et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
分享论文
